Evaluation of mutations in hepatitis C virusNS5A-PKR binding domain on the effect of combination therapy with pegylatedinterferon and ribavirin
碩士 === 國立中興大學 === 生命科學院碩士在職專班 === 98 === Hepatitis C virus (HCV) infection, a leading cause of end-stage liver disease such as cirrhosis or hepatocellular carcinoma. Although therapy with peginterferon and ribavirin will achieve at least a 50% chance of sustained virological response（SVR）, individua...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2009
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/98017660255216741801 |